NY S03591

Establishes "Collaborative Practice Medication Adherence Act" allowing physicians and qualified pharmacists to voluntarily enter into written protocols to manage chronic disease medications for patients not meeting clinical goals of therapy or at risk for hospitalization.

Defines "qualified pharmacist" as one with unrestricted license, minimum two years patient care experience within the last five years, and demonstrated competency in medication adherence through accredited programs.

Authorizes qualified pharmacists under protocol to adjust drug strength, frequency, or route of administration; order disease state laboratory tests; perform routine patient monitoring; and access complete patient medical records with physician notification of changes.

Prohibits qualified pharmacists from substituting different drugs without express physician authorization and requires immediate documentation of all changes in patient medical records.

Makes permanent the provisions of chapter 21 of the laws of 2011 authorizing pharmacists to perform collaborative drug therapy management with physicians by removing the July 1, 2024 expiration date; act takes effect on the 180th day after enactment.